| Product Code: ETC6183396 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The isothermal nucleic acid amplification tests (INAAT) market in Australia is closely aligned with advancements in molecular diagnostics. These tests are known for their ability to amplify DNA or RNA at a constant temperature, making them highly suitable for point-of-care diagnostics. In the context of Australia, the demand for INAAT is increasing due to the growing need for rapid diagnostic tools, especially for infectious diseases like COVID-19, influenza, and sexually transmitted infections. The market`s growth is also supported by the healthcare industry`s push for more accessible and decentralized diagnostic solutions.
Isothermal Nucleic Acid Amplification Tests (INAATs) are gaining popularity in Australia as a diagnostic tool due to their rapid turnaround time and ease of use. With the increasing need for accurate and quick disease diagnostics, especially in emergency settings, INAATs provide a critical advantage in detecting various infections, including viral and bacterial pathogens. The Australian market for INAATs is influenced by the growing demand for decentralized testing solutions, reducing dependence on centralized laboratories. The increasing prevalence of infectious diseases, coupled with advancements in molecular biology and diagnostic technology, supports the growth of this market.
The isothermal nucleic acid amplification tests market in Australia is challenged by limited awareness among healthcare providers compared to conventional testing methods. Achieving regulatory approvals for new diagnostic kits can be a lengthy and costly process. Furthermore, market acceptance in non-hospital settings remains low.
Complementing the above, the tests based on this technology are gaining popularity in Australias diagnostic labs and remote healthcare settings. Investment opportunities exist in localized test kit production, particularly for diseases like COVID-19, influenza, and STDs. Creating affordable, accurate, and easy-to-use kits will attract interest from both public and private healthcare providers.
Isothermal nucleic acid amplification tests (NAATs) are classified as Class 3 or 4 IVDs by the TGA, requiring rigorous pre-market assessments. The government prioritizes fast-tracking high-importance diagnostic tools, especially for infectious diseases, and encourages local manufacturing to reduce import dependency.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Isothermal Nucleic Acid Amplification Tests Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Isothermal Nucleic Acid Amplification Tests Market - Industry Life Cycle |
3.4 Australia Isothermal Nucleic Acid Amplification Tests Market - Porter's Five Forces |
3.5 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.9 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Isothermal Nucleic Acid Amplification Tests Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for rapid and accurate diagnostic tests |
4.2.2 Growing prevalence of infectious diseases in Australia |
4.2.3 Technological advancements in isothermal nucleic acid amplification tests |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of diagnostic tests |
4.3.2 High cost associated with isothermal nucleic acid amplification tests |
4.3.3 Limited awareness and adoption of these tests among healthcare providers |
5 Australia Isothermal Nucleic Acid Amplification Tests Market Trends |
6 Australia Isothermal Nucleic Acid Amplification Tests Market, By Types |
6.1 Australia Isothermal Nucleic Acid Amplification Tests Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Assay and Kit, 2021- 2031F |
6.1.4 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By System, 2021- 2031F |
6.2 Australia Isothermal Nucleic Acid Amplification Tests Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Infectious disease [HIV, Influenza], 2021- 2031F |
6.2.3 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Blood Screening, 2021- 2031F |
6.3 Australia Isothermal Nucleic Acid Amplification Tests Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By LAMP, 2021- 2031F |
6.3.3 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By SDA, 2021- 2031F |
6.3.4 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By NASBA, 2021- 2031F |
6.3.5 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By HAD, 2021- 2031F |
6.3.6 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By NEAR, 2021- 2031F |
6.3.7 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By TMA, 2021- 2031F |
6.3.8 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Others, 2021- 2031F |
6.3.9 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Isothermal Nucleic Acid Amplification Tests Market, By Disease Indication |
6.4.1 Overview and Analysis |
6.4.2 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Coronary angioplasty, 2021- 2031F |
6.4.3 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Venous angioplasty, 2021- 2031F |
6.4.4 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Carotid angioplasty, 2021- 2031F |
6.4.5 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Renal artery angioplasty, 2021- 2031F |
6.4.6 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Peripheral angioplasty, 2021- 2031F |
6.5 Australia Isothermal Nucleic Acid Amplification Tests Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
6.5.4 Australia Isothermal Nucleic Acid Amplification Tests Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Isothermal Nucleic Acid Amplification Tests Market Import-Export Trade Statistics |
7.1 Australia Isothermal Nucleic Acid Amplification Tests Market Export to Major Countries |
7.2 Australia Isothermal Nucleic Acid Amplification Tests Market Imports from Major Countries |
8 Australia Isothermal Nucleic Acid Amplification Tests Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Number of accredited laboratories offering isothermal nucleic acid amplification tests |
8.3 Rate of adoption of isothermal nucleic acid amplification tests by healthcare facilities |
9 Australia Isothermal Nucleic Acid Amplification Tests Market - Opportunity Assessment |
9.1 Australia Isothermal Nucleic Acid Amplification Tests Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Australia Isothermal Nucleic Acid Amplification Tests Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Isothermal Nucleic Acid Amplification Tests Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Australia Isothermal Nucleic Acid Amplification Tests Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.5 Australia Isothermal Nucleic Acid Amplification Tests Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Isothermal Nucleic Acid Amplification Tests Market - Competitive Landscape |
10.1 Australia Isothermal Nucleic Acid Amplification Tests Market Revenue Share, By Companies, 2024 |
10.2 Australia Isothermal Nucleic Acid Amplification Tests Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here